Medtronic Diabetes
Clinical trials sponsored by Medtronic Diabetes, explained in plain language.
-
New 'Artificial Pancreas' system aims for better blood sugar control
Disease control Not yet recruitingThis study is testing a new automated insulin delivery system called the NMX8. It aims to see if this new system is as safe and effective as other commercially available systems at helping adults with type 1 diabetes keep their blood sugar in a healthy range. About 230 participan…
Phase: NA • Sponsor: Medtronic Diabetes • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New 'Artificial Pancreas' system aims for better diabetes control
Disease control Not yet recruitingThis study is testing a new automated insulin delivery system called the MiniMed NMX8 to see if it's as safe and effective as a current model (the 780G system). About 116 people with type 1 or type 2 diabetes who already use the 780G system will try the new device for 12 weeks. T…
Phase: NA • Sponsor: Medtronic Diabetes • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC